Areca nut extracts exert different effects in oral cancer cells depending on serum concentration: A clue to the various oral alterations in betel quid chewers  by Ji, Wen-Tsai et al.
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Betel  quid  chewing  is  associated  with various  pathologic  alterations  in oral  mucosa.  How-
ever, the molecular  mechanism  behind  so  many  contradictory  alterations  remains  unclear.
Here we aimed  to build  a  model  to facilitate  the related  studies  in cultured  cells.  In our
results,  areca  nut  extract  (ANE)  was found  to  exert  different  effects  in  oral  cells  depending  on
the supplemented  serum  level.  ANE  strongly  induced  DNA  damage,  necrotic  ballooning,  and
inﬂammatory cytokines  under  lower  serum  concentration  while  might  convert  to facilitate
deregulated  growth  of  serum-supplemented  cells  via  modulating  the  activity/expression  of
factors such  as  E-cadherin  and  Snail.  Despite  ANE  signiﬁcantly  activated  NF-B,  a mediator
critical  for  inﬂammation,  inhibition  of NF-B  did not  prevent  the  activation  of IL8  promoter.
We  further  discovered  Y705-dephosphorylated  STAT3  might  enhance  IL8  transcription.
Since  necrosis  and  the inﬂammatory  cytokines  could  cause  massive  inﬂammation,  inﬁltra-
tion of interstitial  ﬂuid  might  potentiate  cellular  resistance  against  the  acute  cytotoxicity
of  ANE  and  further  support  the  proliferation  of  transforming  cells.  Induction  of  VEGF  and
angiogenesis  under  lower  serum  condition  also paved  the  way  for cell  growth  and  subse-
quent  metastasis.  Accordingly,  we  concluded  that  in correlation  with  serum  inﬁltration  ANE
caused particular  effects  in  oral  cells  and  possibly  the  various  clinicopathological  alterations
in vivo.
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. IntroductionOral cancer is one of the most common cancers. About
75,000 cases are reported annually worldwide [1]. Oral
quamous cell carcinoma (OSCC) accounts for more than
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90% of oral cancer incidence and is frequently found at
tongue,  buccal, and gingival areas [2]. Compared to normal
tissues, several proteins with aberrant regulation and/or
expression have been found in oral cancer, including epi-
dermal  growth factor receptor (EGFR), Akt, STAT3, cyclin
D1  (CCND1), GSK3, and possibly p21 [3–6].
Consisted of areca nut, inﬂorescence or leaf of Piper
betle, and slaked lime, betel quid has been implicated in
the  high occurrence of oral malignance in south-east Asia
is is an open access article under the CC BY-NC-ND license
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[7]. In addition to the premalignant lesions such as leuko-
plakia,  chewing of betel quid was reported to be highly
associated with the so-called “betel chewer’s mucosa”
featuring with pseudomembranous wrinkle, thickened
epithelium, brownish discoloration, ulcer, and submucosal
ﬁbrosis [8–10]. Histologically, ballooning and vacuolated
cells, round nuclear remnants or pyknotic nuclei, mas-
sive  inﬂammatory inﬁltration, and deregulated epithelial
growth are frequently observed in betel quid chewers
[8–11].
Areca nut, the major component of betel quid, is
considered carcinogenic [12]. Treatment of areca nut
extract (ANE) increased reactive oxygen species (ROS)
and  caused morphological alterations such as retrac-
tion and autophagosome-like vacuoles in cultured cells
[13,14].  In contrast, we recently discovered that ANE
caused ballooning and pyknosis under serum starva-
tion [15]. By inducing miR-23a, ANE reduced Fanconi
anemia group G protein (FANCG) and impeded double-
strand break (DSB) DNA repair [16]. ANE also impaired
cytokinesis and induced micronuclei in Chinese hamster
ovary (CHO) cells [17]. Induction of cytokines interleukin-
6  (IL-6) and interleukin-8 (IL-8) by ANE in peripheral
blood mononuclear cells might partially contribute to
the  mucosa inﬂammatory inﬁltration [18]. Among the
identiﬁed compounds of areca nut, arecoline had been
proven genotoxic and might contribute to oral carcino-
genesis by facilitating error-prone DNA replication [19].
Areca  nut-derived oligomericprocyanidins had also been
demonstrated to induce apoptosis in human lymphocytes
[20].
Betel quid chewing is associated with various alter-
ations in oral mucosa. It remains obscure how so many
different alterations such as deregulated epithelial growth
and  the adjacent ulcerative inﬂammation are induced.
Under normal condition (10% FBS), however, these alter-
ations  could not be easily simulated in cultured cells. In this
study  we aim to build a model for studying the cytopathic
effects of ANE in oral cells that may  facilitate mechanism
research in the future.
2.  Materials and methods
2.1.  Cell culture
OC2,  an oral squamous cell carcinoma cell line derived
from a Taiwanese man  with habits of drinking, smok-
ing, and areca nut chewing, was maintained in RPMI1640
medium supplemented with 10% fetal bovine serum (FBS)
and  1% penicillin/streptomycin. The other oral cancer
cell line SAS were maintained in DMEM with similar
supplements. Cells were routinely kept in a 37 ◦C incu-
bator supplied with 5% CO2 and subcultured every two
to  three days. Twelve to sixteen hours after seeding,
experiments were performed soon after medium refresh-
ing  when cell conﬂuence was about 70–90% except for
the  morphological tests (30–40%). For low serum cul-
ture,  cells were washed twice with and cultured in
medium containing no FBS or 1% FBS immediately before
treatment.ts 1 (2014) 1087–1095
2.2.  Areca nut extract
Areca  nut extract (ANE) was prepared from fresh nuts. In
brief,  the nuts were chopped into about 0.5–1 cm3 dices by
a  blender and the water-soluble ingredients were extracted
at  4 ◦C overnight. The supernatant was harvested and con-
centrated by −70 ◦C lyophilization. The powder derived
from water extract was  weighed, re-dissolved in ddH2O,
and  stored at −20 ◦C before experimental use.
2.3. Reagents and antibodies
Wortmannin,  N-acetylcysteine (NAC), acridine orange
(AO), propidium iodide (PI), and dimethyl sulfoxide
(DMSO) were purchased from Sigma–Aldrich (St. Louis,
MO,  USA). NF-B inhibitor quinazoline (QNZ) was from
Cayman (Ann Arbor, MC,  USA). STAT3 inhibitor NSC74859
was  from Selleckchem (Houston, TX, USA). JAK inhibitor
I  was  from Merck (Billerica, MA,  USA). Antibodies
against GSK3, phosphorylated Akt (T308), phosphory-
lated p70S6K (T389), and epidermal growth factor receptor
(EGFR)  were from Cell Signaling Technology (Danvers,
MA,  USA). Antibodies of phosphorylated GSK3 (S9), p21,
p16,  phosphorylated histone H3 (S10), and cleaved PARP
(24  kDa) were from Epitomics (Burlingame, CA, USA). Anti-
bodies  of ﬁbronectin, snail, STAT3, phosphorylated STAT3
(Y705),  and MCP1 were from Abcam (Cambridge, UK). The
antibody  of cyclin D1 (CCND1) was  from Santa Cruz (Dallas,
TX,  USA). Antibodies of E-cadherin and p27 were from BD
Biosciences (San Jose, CA, USA). The antibody of H2AX was
from  Abnova (Walnut, CA, USA). The IL-8 promoter reporter
was  kindly provided by Dr. Yueh-Hsin Ping (National Yang-
Ming  University, Taiwan). The COX2 promoter reporter
and the NF-B activity reporter were kindly provided by
Dr.  Shih-Ming Huang (National Defense Medical Center,
Taiwan). Human sera were collected from two  healthy
20  to 30 years old Taiwanese males without habits of
smoking, alcohol drinking, and betel quid chewing. Before
collection, the donors were completely informed about the
experimental procedures and agreed on paper consent. The
independently collected sera in different tubes with no
personal information were stored at 4 ◦C and used in exper-
iments  within three days. All the procedures were under
supervision of the donors and the review board in Buddhist
Dalin  Tzu Chi General Hospital, Chia-Yi, Taiwan.
2.4. Acridine orange (AO)/ethidium bromide (EtBr)
staining
For AO/EtBr staining, AO/EtBr mixture was added to the
medium to a ﬁnal concentration of 10 g/ml. Ten minutes
later, cells were washed, kept in PBS and observed imme-
diately under the ﬂuorescence microscope.
2.5. Cell lysate preparation and Western blot
Cell lysate preparation and Western blot were per-
formed as described [19]. The results were the represent-
atives from at least two independent experiments. The
photometric intensity was determined using the software
ImageJ.
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.6. Cell fractionation
After  washing three times with PBS, cells in 10 cm cul-
ure  dishes were scraped into 1 ml  ice-cold fractionation
uffer composed of 250 mM sucrose, 20 mM HEPES (pH
.4),  10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA,
nd  the freshly added 1 mM DTT and protease inhibitor
ocktail (Roche, Basel, Switzerland). After incubation on
ce  for about 5–10 min, cells were passed through gauge
6  needles equipped with 1 ml  syringes 10 times. The
assing-through was centrifuged at 800 × g for 10 min. The
upernatant was harvested as the cytoplasmic fraction and
ixed  with corresponding amount of 4× Laemmli loading
ye.  The pellet, or the nuclear fraction, was washed twice
ith  fractionation buffer by centrifugation and directly dis-
olved  in 300 l 4× Laemmli loading dye. After boiling,
amples in equal amount were run for Western blot.
.7.  Luciferase reporter assay
OC2 cells were transfected with reporter vectors using
urbofect according to manufacturer’s instruction. Six
ours  after transfection in the case of NF-B or 24 h in
ll  other cases, cells were washed twice and continuously
aintained in fresh medium containing indicated concen-
rations  or 1% FBS. After ANE treatment, luciferase activity
as  determined using Dual-Luciferase Reporter Assay kit
Promega,  Madison, WI,  USA) 42 or 24 h after initiation of
he  experiments for NF-B or the other reporters. The used
oses  of NSC74859 and JAK I are 50 and 1 M,  respectively.
or RNA silencing, cells were previously transfected with
ontrol  or NF-B p65 dsRNAs (Cell Signaling Technology,
anvers, MA,  USA) using Lipofectamine 2000 for 24 h. Cells
ere  then washed and continuously transfected with IL-
 or NF-B reporter and treated with ANE as described
bove.
.8. Viability analysis
Cells  at 90% conﬂuence were treated with the indicated
eagents. One day later, MTT  reagent (Sigma, St. Louis, MO,
SA)  with a ﬁnal concentration of 1 mg/ml  was added into
ach  well. Plates were swirled gently for a few seconds and
he  cells were cultured continuously for 3 h. After incu-
ation, the cells were washed twice with PBS and MTT
etabolic product was resuspended in 500 l DMSO. After
wirling  for seconds, 50 l supernatant from each well was
ransferred to optical plates for detection at 595 nm.
.9.  Real-time PCR
Cells  were harvested for RNA extraction using TriPure
eagent (Roche, Basel, Switzerland) 24 h after ANE treat-
ent.  After cDNA synthesis, reaction was conducted
sing BioRad SYBR green kit. Primers for transcripts
uantiﬁcation are: E-cadherin: 5′-CCTGGGACTCC-
CCTACAGA-3′ and 5′-AGGAGTTGGGAAATGTGAGC-
′, vimentin: 5′-GGCTCAGATTCAGGAACAGC-3′and 5′-
TGAATCTCATCCTGCAGGC-3′, IL6: 5′-GAACTCCTTCTCC-
CAAGCGCCTT-3′ and 5′-CAAAAGACCAGTGATGATT-
TCACCAGG-3′, IL8: 5′-TCTGCAGCTCTGTGTGAAGG-3′ andts 1 (2014) 1087–1095 1089
5′-ACTTCTCCACAACCCTCTGC-3′, RANTES: 5′-CGCTGTCA-
TCCTCATTGCTA-3′ and 5′-GCACTTGCCACTGGTGTAGA-3′,
VEGF:  5′-CTTGCTGCTGTACCTCCACCAT-3′ and 5′-TGTTGT-
GCTGTAGGAAGCTCATCT-3′.
2.10. Statistical analysis
The  data were analyzed using t-test and the results with
p  value less than 0.05 were considered signiﬁcant.
3. Results
3.1. Areca nut extracts exert different effects in oral cells
depending on serum concentration
Betel  quid chewing is associated with various mor-
phological alterations in oral cavity. However, several
alterations could not be simulated in normally cultured
cells. High concentration of ANE even caused cell retrac-
tion,  a phenomenon rarely reported in clinical histology.
In  this study, we discovered that ANE could exert partic-
ular  effects on morphology and cellular signaling in oral
cells  under different serum concentrations. ANE evidently
caused ballooning and pyknotic nuclei in serum starved
cells  (Fig. 1A). The increased membrane permeability and
the  evidences including ROS- and Ca2+-dependence in our
previous study suggested ANE induced pyknotic necro-
sis  (Fig. 1B) [15]. In contrast, most serum-supplemented
cells remained intact after treatment of lower doses of
ANE  although cells supplemented with 1% FBS had more
autophagosome-like vacuoles. The sera from two  healthy
adult  males similarly antagonized the ANE-induced bal-
looning  (Fig. S1).
Besides  the morphology alterations, ANE signiﬁcantly
induced DNA damage in cells without sufﬁcient supply of
FBS  as evidenced by the increased H2AX (Fig. 1C). Induc-
tion  of several proteins such as p21 and ﬁbronectin was
also  increased after reducing serum although these two
proteins were barely detectable under serum free condi-
tion  possibly due to loss of cytoplasmic components after
membrane damage or the other unknown mechanisms
(Fig. 1C and Fig. S2). In addition, Akt phosphorylation or
the  level of epidermal growth factor receptor (EGFR) was
downregulated by ANE only in cells supplemented with
1%  FBS (Fig. 1D). As a control, the phosphorylation of a
mTOR  complex 1 activity indicator p70S6K had detectably
decreased at 1% FBS condition. Regulation of other pro-
teins  like GSK3 and cyclin D1 (CCND1), however, was
not  obviously affected by serum concentration except in
necrotic  cells (Fig. 1C). Taken together, these results sug-
gest  that ANE has different physiological effects in oral cells
depending on serum concentration.
3.2. Areca nut extracts enhance expression of
inﬂammatory cytokines particularly under lower serum
conditionAn  important characteristic of betel chewer’s mucosa
is  the massive inﬂammatory inﬁltration. In our results,
ANE signiﬁcantly increased transcripts of several inﬂam-
matory cytokines including IL6, IL8, and RANTES in cells
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ology an
re then
ng the cFig. 1. Serum concentration inﬂuences the effects of ANE on cell morph
concentrations of FBS were treated with 0.5 mg/ml ANE for 24 h. Cells we
brane  damage (B). The other panels of cells were harvested for monitori
representative  ﬁgures from at least two independent experiments.
supplemented with less or no serum (Fig. 2A). Under 1%
FBS  condition, ANE also obviously increased the promoter
activity of IL8 and COX2 (Fig. 2B). Interestingly, we  dis-
covered that ANE increased monocyte chemotactic protein
1  (MCP1) in cells supplemented with 1% FBS (Fig. 2C).
However, it is possible that ANE enhanced deglycosyla-
tion rather than expression of MCP1 since Western blotting
showed that the increase of MCP1 after ANE treatment was
correlated  with signiﬁcant reduction of a high-molecular-
weight form of MCP1. Given that deglycosylated MCP1 has
been  shown to possess higher chemoattractant ability [21],
this  result has further conﬁrmed ANE-induced inﬂamma-
tory inﬁltration under low serum condition.
Since under lower serum concentration ANE is apt to
induce necrosis and inﬂammatory cytokines, inﬁltration of
interstitial  ﬂuid during massive inﬂammation might poten-
tiate  cellular resistance against the acute cytotoxicity of
ANE  and further support the proliferation of transforming
cells. Induction of VEGF and angiogenesis under lower
serum condition also paved the way for cell growth and
subsequent metastasis (Fig. 2A).
3.3. Areca nut extracts activate NF-B under 1% FBS
conditionThe previous results indicated serum concentration
inﬂuenced the effects of ANE on cell appearance and the
levels  of transcripts or proteins. To further conﬁrm thed various proteins. OC2 or the indicated SAS cells cultured with various
 directly photographed (A) or stained with AO/EtBr for evaluating mem-
hanges of indicated proteins by Western blot (C, D). The results are the
impact  on cell signaling, we  investigated the effects of
serum  and ANE on the activity of NF-B, a known inﬂam-
mation mediator [22]. By NF-B reporter assay, we  showed
that  ANE efﬁciently enhanced NF-B activity under 1%
serum  (Fig. 3A). Surprisingly, knock-down of NF-B p65
had  reduced the corresponding reporter activity while con-
versely  enhanced ANE-mediated IL8 reporter activation
(Fig. 3B). Using a NF-B inhibitor quinazoline (QNZ) or
MG132 also could not counteract this effect even in the
case  of IL6 (Fig. S3). In comparison, inhibition of NF-B by
the  same dose of QNZ signiﬁcantly prevented the induction
of  p21 by ANE, conﬁrming the validity of the above exper-
iments (Figs. 3C and S4A). Because the induction is inde-
pendent of reactive oxygen species-mediated DNA damage,
ANE  may  upregulate NF-B signaling to directly increase
p21 (Fig. S4B). NF-B inhibition also obviously increased
ANE cytotoxicity but not PARP cleavage, an indicator of
apoptosis  (Figs. 3D and S4C). Although all these results sug-
gested  ANE indeed activated NF-B to modulate cell func-
tions,  NF-B is not directly involved in the upregulation of
IL8  transcription. ANE might also induce a few inﬂamma-
tory cytokines via a mechanism in addition to NF-B.
3.4.  ANE induces inﬂammatory signaling at least via
enhancing dephosphorylation of STAT3
Like Akt, phosphorylation of STAT3 (Y705) was also
decreased by ANE under lower serum condition (Figs. 4A
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Fig. 2. ANE under lower serum condition induces inﬂammatory cytokines more efﬁciently. (A) OC2 cells cultured with indicated concentrations of FBS
were  treated with 0.5 mg/ml  ANE. The cells were harvested for measurement of IL6, IL8, RANTES or VEGF transcripts 24 h later. The value of the untreated,
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sterisk  might be a glycosylated form of MCP1.
nd S5). Despite that ANE treatment signiﬁcantly reduced
he  phosphorylation of total STAT3 (Y705), the ratio of
uclear  to cytoplasmic localization of unphosphorylated
TAT3 was not altered (Fig. 4B). As a control, ANE enhanced
uclear translocation of Snail proteins. Moreover, inhibi-
ion  of STAT3 dimerization by NSC74859, which reduces
NA-binding STAT3 with IC50 of 86 M,  reduced the acti-
ation of IL8 promoter (Fig. 4C) [23]. In contrast, inhibition
f  STAT3 phosphorylation by JAK inhibitor I, a pan JAK
nhibitor with IC50 value between 1 and 15 nM,  did not
etectably downregulate the reporter activity (Fig. 4C) [24].
his  result suggests STAT3 is required for ANE-induced IL8
ranscription but JAK-mediated Y705 phosphorylation is
ispensable.  Similar effects also could be seen in the trans-
ripts  level of IL6 although the case of IL8 was inconsistent
ossibly because the mRNA stability may  be independently
egulated (data not shown) [25]. These results increase a
ossibility  that ANE enhances inﬂammation in oral mucosa
t  least via facilitating dephosphorylation of nuclear STAT3.
ctivated STAT3 is associated with inﬂammation during
umor  progress [26]. However, ANE may  modulate the tran-
cription  of a few inﬂammatory cytokines by enhancing
705 dephosphorylation of STAT3 since un- and phospho-
ylated STAT3 had been reported to differently regulate
everal downstream targets [27].
. DiscussionIn  this study, we provided a few examples to
rove serum concentration inﬂuenced the effects of
NE  in cultured cells. The effects of ANE under differ-
nt serum condition give a rational explanation to ther COX2 promoter reporter were cultured in medium containing 1% FBS.
ted cells were harvested for Western blot. The upper signal marked with
various  alterations in betel quid chewers. In serum-starved
cells, ANE caused cell ballooning and nuclear pyknosis. The-
oretically,  the environment that oral epithelial cells reside
in  is impossible to be stringently serum free. However,
epithelial tissue normally is avascular and less accessible
to  the circulating nutrients in blood stream. A previous
research indicated the epidermis in average has lower ratio
of  interstitial ﬂuid than dermis [28]. Because in our results
even  0.5% human serum could not completely circumvent
necrosis, these alterations may  hence occasionally occur
in  vivo especially in the superﬁcial cells. The repeated
stimuli of highly concentrated ANE during chewing may
further  increase the chance of pyknotic necrosis.
According to our results, ANE may  enhance deregulated
cell growth via multiple mechanisms. Both dysadherin and
snail  lead to decrease of E-cadherin [29,30]. Besides, ANE
slightly  increased CCND1, a protein critical for cell cycle
progress [31]. ANE also constantly inhibited GSK3 regard-
less  of serum concentration. Because GSK3 is a negative
regulator of proteins including snail and -catenin, hyper-
phosphorylation of GSK3 is common in several tumors
[32,33]. However, it remains unanswered why  inﬂam-
mation and ulcer frequently exist underneath or close
to  hyperplasia lesion in betel quid chewers. A previous
study proved that during carcinogenesis the hyperpla-
sia has had higher interstitial ﬂuid pressure (IFP) due to
abnormal, compressed vasculature system regardless of
the  increased permeability of blood vessels [34]. Elevated
IFP  hinders transport and tumors which similarly have
higher IFP hence are less accessible to therapeutic chem-
icals.  In contrast, inﬂammation stimuli reduce IFP and
result  in inﬁltration of interstitial ﬂuid and edema [35]. Our
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Fig. 3. ANE increases NF-B activity. (A) OC2 cells transfected with NF-B activity reporter were maintained with indicated concentrations of FBS. Cells
were  harvested for luciferase assay 24 h after treatment of 0.5 mg/ml ANE. (B) Cells sequentially transfected with NF-B p65 siRNA and IL8 promoter
ted wit
 QNZ wereporter  or NF-B activity reporter were cultured in medium supplemen
after  treatment. (C, D) Cells treated with ANE in combination or not with
previous study had proven insulin is a key component in
serum  to counteract ANE-induced ballooning [15]. Since
the  half-life of insulin in circulation is only minutes, it is
highly  possible that ANE could strongly induce inﬂamma-
tion and ulcer in the region where insulin is insufﬁcient
[36]. Signiﬁcant increase of ﬁbronectin under lower serum
condition also possibly enhances ﬁbrosis.
Interestingly, the survival rate of ANE-treated cells was
obviously increased in the presence of higher serum con-
centration. In contrast to inhibition of STAT3 dimerization,
in our results inhibition of NF-B weakly impeded the
induction of IL6 and IL8 by ANE. ANE possibly induce
inﬂammation in part by reducing STAT3 Y705 phosphory-
lation in cells supplemented with less serum. Because un-
and  phosphorylated STAT3 had been reported to differently
regulate several downstream targets, ANE may  thus mod-
ulate  the activity of particular genes depending on serum
conditions [27]. However, it should not be ruled out that
ANE  may  oppositely regulate the phosphorylation of STAT3
S727.  Given that ANE is apt to induce necrosis and inﬂam-
matory cytokines under low serum condition, the resulted
massive inﬂammation and inﬁltration of interstitial ﬂuid
in  oral mucosa may  increase cellular resistance against the
acute  cytotoxicity of ANE. Considering that hyperplasia is
frequently  accompanied with inﬂammatory inﬁltrate, it ish 1% FBS. Cells were harvested for evaluating the luciferase activity 24 h
re harvested for Western blot or for MTT  assay 24 h later.
possible  that ANE may  exacerbate oral carcinogenesis after
massive  inﬂammation or angiogenesis [8]. Although it is
widely  accepted that ANE can cause cytotoxic effects in
cultured  cells, we  found that ANE could upregulate some
prosurvival signaling, which increased the possibility of
malignant transformation. Supporting this speculation is
the  result that survivin was  detectably increased by ANE
in  OC2 cells (Fig. S6). ANE also obviously induced HIF1,
the  master regulator of hypoxia adaptation, via activating
ERK (Fig. S6). In addition, activation of NF-B appeared to
favor  cell survival during ANE treatment in spite of the
potential side effect, cell cycle retardation. As a cyclin-
dependent kinase (CDK) inhibitor, p21 is well known as
a  negative regulator of cell proliferation [37]. However,
increasing evidence has suggested that nuclear p21 may
not  simply induce cell cycle arrest. Accumulation of p21
in  the nucleus has been shown to be correlated with poor
prognosis and disease progress in OSCC [38,39]. Interest-
ingly, p21 may  facilitate G1/S transition after assembling
into CCND1/Cdk2/p21/PCNA complex unless cyclin E/Cdk2
is  sequestered by excessive p21 proteins [40,41]. Given that
ANE-induced p21 retards cell cycle, cells may  continue pro-
liferation  once areca nut is removed after chewing.
In surviving cells, ANE possibly triggers transformation
via mechanisms besides the ROS-mediated DNA damage.
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Fig. 4. ANE induces dephosphoylation of STAT3. OC2 cells cultured with various concentrations of or 1% FBS were treated with 0.5 mg/ml  ANE. Twenty-
four  hours after treatment, cells were directly harvested for Western blot (A) or fractionated for evaluating the localization of STAT3 (B). The effect of
ANE  on STAT3 phosphorylation in two  independent experiments was  demonstrated after normalization to each untreated sample (A, lower panel). The
value  of each untreated sample under different FBS conditions was  deﬁned as 1. (C) Cells transfected with IL8 promoter reporter were treated with ANE in
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n the shown examples, however, it is unclear how and
hy  EGFR and Akt were downregulated by ANE at lower
erum  concentration. Although Akt is commonly known
s  an oncoprotein, accumulating evidence has suggested
hat like Ras, overactivated Akt may  induce senescence
nder speciﬁc circumstances [42]. Because Akt could sen-
itize  cells to ROS-mediated apoptosis, downregulation of
kt  activity might facilitate early carcinogenesis induced
y  ANE [43]. Once nutrients and serum are sufﬁciently
vailable especially after angiogenesis, activation of EGFR
nd  Akt signaling possibly accelerates the progression of
SCC.
Taken  together, by manipulating FBS concentration
e discovered that ANE differentially determined cel-
ular  destiny, thus delineating a possible progression of
NE-mediated oral carcinogenesis (Fig. 5). Without the
nterference from exogenous growth factors, the effects of
NE  on epithelial-mesenchymal transition are also easierK I are 50 and 1 M,  respectively. The luciferase activity was determined
to  observe in cells supplemented with less FBS. Our results
give  a potential model for the simulation of ANE-mediated
pathogenesis in culture cells.
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Fig. 5. A proposed model for ANE-mediated carcinogenesis and various alterations. ANE steadily enhances deregulated cell growth and the resulted
ing insu
ransform
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[hyperplasia  lesion gradually suffers from shortage of supplements includ
and  ROS. Subsequently, inﬁltration and angiogenesis support survival of t
carcinogenesis.
Transparency document
The  Transparency document associated with this article
can be found in the online version.
Acknowledgement
This work was partially supported by National Sci-
ence Council (97-2311-B-194-001-MY3) and no additional
external funding was received for this study.
Appendix A. Supplementary data
Supplementary data associated with this article can
be  found, in the online version, at doi:10.1016/j.toxrep.
2014.10.018.
References
[1] S. Warnakulasuriya, Global epidemiology of oral and oropharyngeal
cancer, Oral Oncol. 45 (2009) 309–316.
[2]  Y.K. Chen, H.C. Huang, L.M. Lin, C.C. Lin, Primary oral squamous cell
carcinoma: an analysis of 703 cases in southern Taiwan, Oral Oncol.
35  (1999) 173–179.
[3] F.I. Daniel, M. Fava, R. da Rocha Hoffmann, M.M.  Campos, L.S. Yugel,
Main  molecular markers of oral squamous cell carcinoma, Appl. Can-
cer  Res. 30 (2010) 279–288.
[4] K.O. Hong, J.H. Kim, J.S. Hong, H.J. Yoon, J.I. Lee, S.P. Hong, S.D. Hong,
Inhibition of Akt activity induces the mesenchymal-to-epithelial
reverting transition with restoring E-cadherin expression in KB and
KOSCC-25B oral squamous cell carcinoma cells, J. Exp. Clin. Cancer
Res.  28 (2009) 1.
[5] R. Mishra, Glycogen synthase kinase 3 beta: can it be a target for oral
cancer,  Mol. Cancer 9 (2010) 144.
[6]  N.G. Shah, T.I. Trivedi, R.A. Tankshali, J.A. Goswami, D.H. Jetly, T.P.
Kobawala, S.N. Shukla, P.M. Shah, R.J. Verma, Stat3 expression in
oral  squamous cell carcinoma: association with clinicopathological
parameters and survival, Int. J. Biol. Markers 21 (2006) 175–183.
[7] I. Chiba, Prevention of betel quid chewers’ oral cancer in the
Asian-Paciﬁc area, Asian Pac. J. Cancer Prev. 2 (2001) 263–269.
[8] C.T. Chiu, S.Y. Lee, D.J. Wang, Y.C. Liu, W.F. Chang, C.Y. Yen,
C.H. Lee, S.Y. Liu, Matrix metalloproteinase-1 expression in betel
quid-associated oral cancers, J. Dent. Sci. 3 (2008) 75–82.
[9] P.A. Reichart, H.P. Phillipsen, Betel chewer’s mucosa – a review, J.
Oral  Pathol. Med. 27 (1998) 239–242.
10] C.R. Trivedy, G. Craig, S. Warnakulasuriya, The oral health conse-
quences of chewing areca nut, Addict. Biol. 7 (2002) 115–125.
11] R. Rajendran, B. Sivapathasundharam, Shafer’s Textbook of Oral
Pathology, 6th ed., Elsevier, 2009, pp. 96.
[lin. Under such condition, ANE obviously induces inﬂammation, necrosis,
ing cells. Finally, recovered activity of Akt and EGFR may  exacerbate the
12] J.H. Jeng, M.C. Chang, L.J. Hahn, Role of areca nut in betel
quid-associated chemical carcinogenesis: current awareness and
future  perspectives, Oral Oncol. 37 (2001) 477–492.
13] M.C. Chang, Y.S. Ho, P.H. Lee, C.P. Chan, J.J. Lee, L.J. Hahn, Y.J. Wang,
J.H.  Jeng, Areca nut extract and arecoline induced the cell cycle arrest
but  not apoptosis of cultured oral KB epithelial cells: association of
glutathione, reactive oxygen species and mitochondrial membrane
potential, Carcinogenesis 22 (2001) 1527–1535.
14]  H.H. Lu, S.Y. Kao, T.Y. Liu, S.T. Liu, W.P. Huang, K.W. Chang, S.C. Lin,
Areca  nut extract induced oxidative stress and upregulated hypoxia
inducing factor leading to autophagy in oral cancer cells, Autophagy
6  (2010) 725–737.
15] W.-T. Ji, C.-I. Lee, J.Y.-F. Chen, Y.-P. Cheng, S.-R. Yang, J.-H. Chen, H.-R.
Chen, Areca nut extract induces pyknotic necrosis in serum-starved
oral cells via increasing reactive oxygen species and inhibiting
GSK3b: an implication for cytopathic effects in betel quid chewers,
PLOS ONE 8 (2013) e63295.
16] Y.S. Tsai, C.S. Lin, S.L. Chiang, C.H. Lee, K.W. Lee, Y.C. Ko, Areca nut
induces miR-23a and inhibits repair of DNA double-strand breaks by
targeting  FANCG, Toxicol. Sci. 123 (2011) 480–490.
17]  C.C. Lin, M.C. Chang, H.H. Chang, T.M. Wang, W.Y. Tseng, T.F. Tai, H.W.
Yeh,  T.T. Yang, L.J. Hahn, J.H. Jeng, Areca nut-induced micronuclei
and cytokinesis failure in Chinese hamster ovary cells is related to
reactive  oxygen species production and actin ﬁlament deregulation,
Environ. Mol. Mutagen. 50 (2009) 367–374.
18]  L.Y. Chang, H.C. Wan, Y.L. Lai, T.Y. Liu, S.L. Hung, Enhancing effects
of  areca nut extracts on the production of interleukin-6 and
interleukin-8 by peripheral blood mononuclear cells, J. Periodontol.
77 (2006) 1969–1977.
19] W.T. Ji, S.R. Yang, J.Y. Chen, Y.P. Cheng, Y.R. Lee, M.K. Chiang, H.R. Chen,
Arecoline  downregulates levels of p21 and p27 through the reactive
oxygen species/mTOR complex 1 pathway and may  contribute to oral
squamous  cell carcinoma, Cancer Sci. 103 (2012) 1221–1229.
20] C.C. Wang, P.L. Huang, T.Y. Liu, T.R. Jan, Highly oligomeric procyani-
dins from areca nut induce lymphocyte apoptosis via the depletion
of  intracellular thiols, Toxicol. In Vitro 23 (2009) 1234–1241.
21] Z.G. Liu, A. Haelens, A. Wuyts, S. Struyf, X.W. Pang, P. Proost, W.F.
Chen, J. van Damme, Isolation of a lymphocyte chemotactic factor
produced by the murine thymic epithelial cell line MTEC1: identiﬁ-
cation as a 30 kDa glycosylated form of MCP-1, Eur. Cytokine Netw.
7  (1996) 381–388.
22] T. Lawrence, The nuclear factor NF-B pathway in inﬂammation, Cold
Spring  Harb. Perspect. Biol. 1 (2009) a001651.
23]  K. Siddiquee, S. Zhang, W.C. Guida, M.A. Blaskovich, B. Greedy, H.R.
Lawrence, M.L.R. Yip, R. Jove, M.M.  McLaughlin, N.J. Lawrence, S.M.
Sebti,  J. Turkson, Selective chemical probe inhibitor of Stat3, iden-
tiﬁed  through structure-based virtual screening, induces antitumor
activity, Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 7391–7396.
24] Y. Matsunaga, H. Inoue, S. Fukuyama, H. Yoshida, A. Moriwaki, T. Mat-
sumoto,  K. Matsumoto, Y. Asai, M.  Kubo, A. Yoshimura, Y. Nakanishi,
Effects of a Janus kinase inhibitor, pyridone 6, on airway responses
in a murine model of asthma, Biochem. Biophys. Res. Commun. 404
(2011)  261–267.
25] E. Hoffmann, O. Dittrich-Breiholz, H. Holtmann, M.  Kracht, Multiple
control of interleukin-8 gene expression, J. Leukoc. Biol. 72 (2002)
847–855.
y Repor
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[W.-T. Ji et al. / Toxicolog
26] H. Yu, D. Pardoll, R. Jove, STAT3 in cancer inﬂammation and immu-
nity:  a leading role for STAT3, Nat. Rev. Cancer 9 (2009) 798–809.
27] J. Yang, M.  Chatterjee-Kishore, S.M. Staugaitis, H. Nguyen, K.
Schlessinger, et al., Novel roles of unphosphorylated STAT3 in
oncogenesis and transcriptional regulation, Cancer Res. 65 (2005)
939–947.
28]  W.  Groenendaal, G. von Basum, K.A. Schmidt, P.A. Hilbers, N.A. van
Riel,  Quantifying the composition of human skin for glucose sensor
development, J. Diabetes Sci. Technol. 4 (2010) 1032–1040.
29] Y. Ino, M.  Gotoh, M. Sakamoto, K. Tsukagoshi, S. Hirohashi,
Dysadherin, a cancer-associated cell membrane glycoprotein,
down-regulates E-cadherin and promotes metastasis, Proc. Natl.
Acad.  Sci. U.S.A. 99 (2002) 365–370.
30] H. Peinado, E. Ballestar, M.  Esteller, A. Cano, Snail mediates
E-cadherin repression by the recruitment of the sin3A/histone
deacetylase 1 (HDAC1)/HDAC2 complex, Mol. Cell. Biol. 24 (2004)
306–319.
31]  J. Eeckhoute, J.S. Carroll, T.R. Geistlinger, M.I. Torres-Arzayus, M.
Brown,  A cell-type-speciﬁc transcriptional network required for
estrogen regulation of cyclin D1 and cell cycle progression in breast
cancer,  Genes Dev. 20 (2006) 2513–2526.
32]  J. Luo, Glycogen synthase kinase 3 (GSK3) in tumorigenesis and
cancer chemotherapy, Cancer Lett. 273 (2009) 194–200.
33] B.P. Zhou, J. Deng, W.  Xia, J. Xu, Y.M. Li, M.  Gunduz, M.  Hung, Dual
regulation of snail by GSK3-mediated phosphorylation in con-
trol  of epithelial-mesenchymal transition, Nat. Cell Biol. 6 (2004)
931–940.
34] J. Hagendoorn, R. Tong, D. Fukumura, Q. Lin, J. Lobo, T.P. Padera, L. Xu,
R.  Kucherlapati, R.K. Jain, Onset of abnormal blood and lumphatic
[ts 1 (2014) 1087–1095 1095
vessel function and interstitial hypertension in early stages of car-
cinogenesis, Cancer Res. 66 (2006) 3360–3364.
35]  H. Wigg, Pathophysiology of tissue ﬂuid accumulation in inﬂamma-
tion, J. Physiol. 589 (2011) 2945–2953.
36] W.C. Duckworth, B.G. Bennett, F.G. Hamel, Insulin degradation:
progress and potential, Endocr. Rev. 19 (1998) 608–624.
37] A.L. Gartel, M.S. Serfas, A.L. Tyner, p21 – negative regulator of the cell
cycle,  Proc. Soc. Exp. Biol. Med. 213 (1996) 138–149.
38]  J.A. Nemes, Z. Nemes, I.J. Marton, p21WAF1/CIP1 expression is a
marker  of poor prognosis in oral squamous cell carcinoma, J. Oral
Pathol.  Med. 34 (2005) 274–279.
39] M.L. Schoelch, J.A. Regezi, N.P. Dekker, I.O. Ng, A. McMillan, et al., Cell
cycle  proteins and the development of oral squamous cell carcinoma,
Oral Oncol. 35 (1999) 333–342.
40] M.  Law, E. Forrester, A. Chytil, P. Corsino, G. Green, et al., Rapamycin
disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell
nuclear antigen complexes and cyclin D1 reverses rapamycin action
by  stabilizing these complexes, Cancer Res. 66 (2006) 1070–1080.
41] C.P. Masamha, D.M. Benbrook, Cyclin D1 degradation is sufﬁcient to
induce  G1 cell cycle arrest despite constitutive expression of cyclin
E2  in ovarian cancer cells, Cancer Res. 69 (2009) 6565–6572.
42] M.V. Astle, K.M. Hannan, P.Y. Ng, R.S. Lee, A.J. George, et al., AKT
induces senescence in human cells via mTORC1 and p53 in the
absence of DNA damage: implications for targeting mTOR during
malignancy, Oncogene 31 (2012) 1949–1962.
43]  V. Nogueira, Y. Park, C.C. Chen, P.Z. Xu, M.L. Chen, et al., Akt deter-
mines replicative senescence and oxidative or oncogenic premature
senescence and sensitizes cells to oxidative apoptosis, Cancer Cell 14
(2008)  458–470.
